Graft-versus-host disease: Proteomics comes of age

Blood

Volumn 113, Issue 2, 2009, Pages 271-272

  Socié, Gerard ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 8; SCATTER FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BIOPSY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT VERSUS HOST REACTION; HIGH THROUGHPUT SCREENING; MICROARRAY ANALYSIS; MORTALITY; NOTE; OUTCOME ASSESSMENT; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SURVIVAL;

EID: 61849106482     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-185991     Document Type: Note

References (3)

1. Kaiser T, Kamal H, Rank A, et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood. 2004;104:340-349.
2. Weissinger EM, Schiffer E, Hertenstein B, et al. Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood. 2007;109:5511-5519.
3. Srinivasan R, Daniels J, Fusaro V, et al. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Exp Hematol. 2006;34:796-801.